NS5A Sequence Heterogeneity of Hepatitis C Virus Genotype 4a Predicts Clinical Outcome of Pegylated-Interferon-Ribavirin Therapy in Egyptian Patients

Journal of Clinical Microbiology- United States

doi 10.1128/jcm.02109-12

Full Text

Abstract

Available in

Categories

Date

September 19, 2012

Authors

Publisher

American Society for Microbiology

Related search

Safety and Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Combination in Treatment of Egyptian Patients With Chronic Hepatitis C Genotype-4

IOSR Journal of Pharmacy (IOSRPHR)

English

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research

English

Hepatitis C Virus Core Protein Substitutions Affect the Response to Pegylated-Interferon and Ribavirin Therapy

English

Quasispecies of Genotype 4 of Hepatitis C Virus Genomes in Saudi Patients Managed With Interferon Alfa and Ribavirin Therapy

Annals of Saudi Medicine

English

Sofosbuvir, Ribavirin and Pegylated Interferon for a Daclatasvir-Resistent Genotype 3 Hepatitis C Virus: Case Report and Review

Revista do Instituto de Medicina Tropical de Sao Paulo

Infectious Diseases

English

The Effect of Pegylated Interferon-Alpha2b and Ribavirin Combination Therapy for Chronic Hepatitis C Infection in Elderly Patients

BMC Research Notes

Molecular Biology

English

Pegylated Interferon and Ribavirin Combination Therapy for Chronic Hepatitis C Associated With Thyroid Dysfunction

Acta Hepatologica Japonica

English

Depressive Episode Incidence in Patients With Chronic Hepatitis C Treated With Pegylated Interferon and Ribavirin

Arquivos de Gastroenterologia

Gastroenterology

English

Decrease in Regulatory T-Cell Function in Chronic Hepatitis C Patients Receiving Pegylated-Interferon Plus Ribavirin

International Journal of Infectious Diseases

Infectious Diseases

English